A crucial part of the Rainbow Cancer Center’s mission is to make significant scientific discoveries about blood disorders and cancers, and bring them rapidly to our patients’ care.
This is accomplished through “translational research,” in which basic scientists in the laboratory collaborate with clinicians at the bedside to find new therapies, drugs and medical devices that will change the way cancer is treated.
Some of our current research drives include:
- Working with University Hospitals of Cleveland’s Center for Genetics to research the predisposition and diagnosis of recurrent and secondary malignancies.
- Pursuing high-impact clinical and basic research, leading to innovative approaches to the diagnosis, treatment and prevention of cancer
- Working in collaboration with the pharmaceutical industry and the federal government to identify and test new agents, bringing new treatment options to children as fast as possible.
- Understanding what makes cancer cells start growing and on finding new ways to control cell growth
- Translating pioneering therapies from the lab bench to the bedside
- Becoming a leader in developing new therapeutic approaches